Comparison Study of SIBP's MMR Vaccine Versus GSK MMR Vaccine in Children Aged 9-11 Months

Clinical trial NCT06399003 · COMPLETED

Trial details

NCT number: NCT06399003
Sponsor: Shanghai Institute Of Biological Products
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Measles-Mumps-Rubella

Start date: 2024-06-28
Primary completion: 2024-09-15
Enrollment: 1200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.